Alinsa, Ellaine S.
HRN: 09-26-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/21/2024
08/27/2024
IV
4.5g
Q8
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes